The Central European Journal of Urology, published by the Polish Urological Association, serves as a vital platform for the dissemination of cutting-edge research in the field of urology. Established in 2009 and continuing through 2024, this journal aims to foster innovation and collaboration among researchers, clinicians, and students by offering a forum for high-quality, peer-reviewed articles that highlight advancements in urological science and practice. Currently holding a Scopus rank of #68 out of 120 in the Medicine_Urology category, and a 2023 quartile ranking of Q3, it is positioned to provide valuable insights into emerging trends and techniques. Although being a subscription-based journal, it remains crucial for professionals seeking to stay updated on the latest developments in urology, contributing significantly to the global conversation in this specialty. With its strong ties to the academic community and dedication to excellence, the Central European Journal of Urology continues to be an indispensable resource for those advancing knowledge and practice in urology.

Surgical Oncology Clinics of North America, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of surgical oncology and surgery, captivating readers since its inception in 1995. With ISSN 1055-3207 and E-ISSN 1558-5042, this esteemed journal offers a comprehensive platform for the dissemination of cutting-edge research, clinical studies, and expert reviews pertaining to surgical techniques and oncological advancements. The journal currently holds a commendable Q3 ranking in Oncology and a Q2 ranking in Surgery, underpinned by its impressive Scopus rankings that place it in the top 25% of its category in Medicine, particularly in the surgical domain (Rank #137/551). Although it does not operate under an open-access model, the insights shared within its pages are invaluable for researchers, healthcare professionals, and students dedicated to enhancing patient outcomes in surgical oncology. With a commitment to advancing medical knowledge, Surgical Oncology Clinics of North America remains a crucial resource for those pursuing excellence in surgical practices and oncology treatment methodologies.

NEUROUROLOGY AND URODYNAMICS is a prestigious peer-reviewed journal published by WILEY, focusing on the intersection of neurology and urology. Since its inception in 1982, this journal has developed a strong reputation, evidenced by its impressive Q2 rankings in both the neurology (clinical) and urology categories as of 2023. With a Scopus rank of #38 out of 120 in Medicine (Urology) and #184 out of 400 in Medicine (Neurology), it occupies a significant position in the academic landscape, casting light on the complex interactions between the nervous and urinary systems. Although the journal does not currently offer open access options, it remains a critical resource for researchers, clinicians, and students seeking to advance their understanding of urodynamics and neurological disorders impacting urological health. With its broad scope and commitment to advancing scientific discourse, NEUROUROLOGY AND URODYNAMICS continues to be an essential publication in enhancing the global dialogue within these interrelated fields.

BJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

Current Bladder Dysfunction Reports, published by SPRINGER, serves as a pivotal journal within the specialized realm of urology and bladder dysfunction, aiming to bridge the gap between basic and clinical research. With an ISSN of 1931-7212 and an E-ISSN of 1931-7220, this publication has maintained a strong focus on the molecular and biochemical aspects of bladder function, evolving from 2006 to the present. Despite currently being categorized in the Q4 tier for both Biochemistry and Molecular Biology, the journal plays a crucial role in disseminating valuable insights, research trends, and contemporary findings in bladder dysfunction. Although it does not offer open access, its contributions remain essential for researchers, clinicians, and students who are seeking to enhance their understanding of bladder-related pathologies and therapeutic strategies. As the field advances, Current Bladder Dysfunction Reports aims to support the exchange of innovative ideas, fostering an environment conducive to progress in the management and treatment of bladder dysfunction issues.

Urologie is a prestigious academic journal published by Springer Heidelberg, focusing on the dynamic and evolving field of urology. With its ISSN 2731-7064 and E-ISSN 2731-7072, this journal serves as a vital platform for disseminating innovative research, clinical studies, and reviews that contribute to the advancement of knowledge in urological science. Established with a commitment to publish high-quality, peer-reviewed articles, Urologie has quickly established its importance in the field, as evidenced by its ranking in the Q3 category of the latest urology quartiles and its position at 81/120 in Scopus, placing it in the 32nd percentile among journals in medicine-related urology. Operating from its location in Heidelberg, Germany, the journal aims to facilitate open dialogue and collaboration among researchers, clinicians, and healthcare professionals. While currently not an open access journal, the insights and findings available in its pages are invaluable for advancing clinical practices and enhancing patient care in urology. With coverage spanning from 2022 to 2024, Urologie invites scholars and practitioners alike to contribute to this critical discourse within the urological community.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

Actas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.